Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

ClinicalTrials.gov ID: NCT02589847

Public ClinicalTrials.gov record NCT02589847. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Efficacy and Safety Assessment of Rebiotix RBX2660 (Microbiota Suspension) for the Treatment of Recurrent Clostridium Difficile Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate efficacy and safety information about RBX2660 for the treatment of recurrent Clostridium difficile infection (CDI), and will compare the efficacy of one treatment with RBX2660 versus antibiotic-treated historical controls. Enrolled subjects will receive one treatment consisting of two doses of RBX2660 (microbiota suspension).

Study identification

NCT ID
NCT02589847
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Rebiotix Inc.
Industry
Enrollment
272 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2015 (Actual)
Primary completion
Jun 2017 (Actual)
Completion
Mar 2019 (Actual)
Last update posted
Mar 26, 2021

2015 – 2019

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Not listed Phoenix Arizona 85054 —
Not listed North Little Rock Arkansas 72117 —
Not listed Sacramento California 95817 —
Not listed Bay Pines Florida 33744 —
Not listed Coral Springs Florida 33065 —
Not listed Gainesville Florida 32610 —
Not listed Miami Florida 33101 —
Not listed Idaho Falls Idaho 83404 —
Not listed Chicago Illinois 60637 —
Not listed Maywood Illinois 60153 —
Not listed Indianapolis Indiana 46260 —
Not listed Lafayette Indiana 47904 —
Not listed Lexington Kentucky 40506 —
Not listed Detroit Michigan 48202 —
Not listed Rochester Minnesota 55905 —
Not listed Saint Paul Minnesota 55130 —
Not listed St Louis Missouri 63110 —
Not listed Omaha Nebraska 68198 —
Not listed Flushing New York 11355 —
Not listed Rochester New York 14618 —
Not listed Syracuse New York 52325 —
Not listed The Bronx New York 10468 —
Not listed Fargo North Dakota 58122 —
Not listed Lima Ohio 45801 —
Not listed Jackson Tennessee 38305 —
Not listed Houston Texas 77025 —
Not listed Springfield Virginia 22150 —
Not listed Virginia Beach Virginia 23454 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02589847, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2021 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02589847 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →